Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Casan
Short Diagnosis-To-Treatment Interval Is Associated With High Risk and Poor Outcomes in Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
R-Ivac Salvage Therapy in Relapsed and Refractory DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma
Sao Paulo Medical Journal
Medicine
Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis
Current Biomarker Findings
Biochemistry
Clinical Biochemistry
Diffuse Large B-Cell Lymphoma With Primary Treatment Failure: Ultra-High Risk Features and Benchmarking for Experimental Therapies
American Journal of Hematology
Hematology
Diffuse Large B-Cell Lymphoma
Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies
Oncologist
Cancer Research
Medicine
Oncology
Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study
Blood Cancer Journal
Oncology
Hematology
Oncologist Volume and Outcomes in Older Adults Diagnosed With Diffuse Large B Cell Lymphoma
Cancer
Cancer Research
Oncology
Hitting Back at Lymphoma: How Do Modern Diagnostics Identify High‐risk Diffuse Large B‐cell Lymphoma Subsets and Alter Treatment?
Cancer
Cancer Research
Oncology
High-Risk Patients With Diffuse Large B-Cell Lymphoma Are Not Enrolled on Clinical Trials
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology